König J - Search Results

1

Associations between various markers of intestinal barrier and immune function after a high-intensity exercise challenge.

Roca Rubio MF, Folkesson M, Kremp C, Evertsson N, Repsilber D, Eriksson U, Ganda Mall JP, Kadi F, Brummer RJ, König J. Roca Rubio MF, et al. Among authors: konig j. Physiol Rep. 2024 May;12(10):e16087. doi: 10.14814/phy2.16087. Physiol Rep. 2024. PMID: 38783385 Free PMC article.

2

Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome.

König J, Brummer RJ. König J, et al. Benef Microbes. 2014 Sep;5(3):247-61. doi: 10.3920/BM2013.0033. Benef Microbes. 2014. PMID: 24583610 Review.

3

Consensus report: faecal microbiota transfer - clinical applications and procedures.

König J, Siebenhaar A, Högenauer C, Arkkila P, Nieuwdorp M, Norén T, Ponsioen CY, Rosien U, Rossen NG, Satokari R, Stallmach A, de Vos W, Keller J, Brummer RJ. König J, et al. Aliment Pharmacol Ther. 2017 Jan;45(2):222-239. doi: 10.1111/apt.13868. Epub 2016 Nov 27. Aliment Pharmacol Ther. 2017. PMID: 27891639 Free PMC article. Review.

4

Randomized clinical trial: Effective gluten degradation by Aspergillus niger-derived enzyme in a complex meal setting.

König J, Holster S, Bruins MJ, Brummer RJ. König J, et al. Sci Rep. 2017 Oct 12;7(1):13100. doi: 10.1038/s41598-017-13587-7. Sci Rep. 2017. PMID: 29026170 Free PMC article. Clinical Trial.

5

Is an enzyme supplement for celiac disease finally on the cards?

König J, Brummer RJ. König J, et al. Expert Rev Gastroenterol Hepatol. 2018 Jun;12(6):531-533. doi: 10.1080/17474124.2018.1473762. Epub 2018 May 11. Expert Rev Gastroenterol Hepatol. 2018. PMID: 29730969 No abstract available.

6

The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study.

Holster S, Lindqvist CM, Repsilber D, Salonen A, de Vos WM, König J, Brummer RJ. Holster S, et al. Among authors: konig j. Clin Transl Gastroenterol. 2019 Apr;10(4):e00034. doi: 10.14309/ctg.0000000000000034. Clin Transl Gastroenterol. 2019. PMID: 31009405 Free PMC article. Clinical Trial.

7

Allogenic Faecal Microbiota Transfer Induces Immune-Related Gene Sets in the Colon Mucosa of Patients with Irritable Bowel Syndrome.

Holster S, Hooiveld GJ, Repsilber D, Vos WM, Brummer RJ, König J. Holster S, et al. Among authors: konig j. Biomolecules. 2019 Oct 8;9(10):586. doi: 10.3390/biom9100586. Biomolecules. 2019. PMID: 31597320 Free PMC article. Clinical Trial.

8

Faecal microbiota transplantation in IBS - new evidence for success?

König J, Brummer RJ. König J, et al. Nat Rev Gastroenterol Hepatol. 2020 Apr;17(4):199-200. doi: 10.1038/s41575-020-0282-z. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32107473 No abstract available.

9

Faecal microbiota transfer in patients with microscopic colitis - a pilot study in collagenous colitis.

Holster S, Rode J, Bohr J, Kumawat AK, Veress G, Hultgren Hörnquist E, Brummer RJ, König J. Holster S, et al. Among authors: konig j. Scand J Gastroenterol. 2020 Dec;55(12):1454-1466. doi: 10.1080/00365521.2020.1839544. Epub 2020 Nov 3. Scand J Gastroenterol. 2020. PMID: 33142068 Free article.

10

Correlations between microbiota and metabolites after faecal microbiota transfer in irritable bowel syndrome.

Holster S, Repsilber D, Geng D, Hyötyläinen T, Salonen A, Lindqvist CM, Rajan SK, de Vos WM, Brummer RJ, König J. Holster S, et al. Among authors: konig j. Benef Microbes. 2021 Feb 24;12(1):17-30. doi: 10.3920/BM2020.0010. Epub 2020 Dec 22. Benef Microbes. 2021. PMID: 33350360 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

974 results

Search Page

Filters